Market Cap

Repare Therapeutics Inc. Market Capitalization:

$110.8 Million

USD as of Jan. 1, 2026

business Repare Therapeutics Inc. Company Profile

Repare Therapeutics Inc. Main Stock Listing

NASDAQ: RPTX

Market Capitalization History of Repare Therapeutics Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Repare Therapeutics Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $110.8 M 108.39%
Jan. 1, 2025 $53.2 M -81.25%
Jan. 1, 2024 $283.5 M -47.42%
Jan. 1, 2023 $539.2 M -16.72%
Jan. 1, 2022 $647.5 M -58.42%
Jan. 1, 2021 $1.56 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Repare Therapeutics Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Repare Therapeutics Inc. has the following listings and related stock indices.


Stock: NASDAQ: RPTX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.